NCT06109324

Brief Summary

Based on the findings of meta-analyses, upper limb robotic rehabilitation has shown to enhance daily living activities, motor function, and strength in stroke patients. However, when compared to traditional methods, recent randomized controlled trials conducted on larger participant groups failed to identify significant differences in motor-related outcomes between the two approaches. In addition to motor deficits, stroke survivors often experience cognitive decline and sensory disturbances, which can significantly impede their recovery process. The introduction of multisensory stimulation and an enriched environment through robotic interventions may offer valuable supplementary treatments in these specific areas. Nevertheless, this aspect of treatment has not been thoroughly explored. This study seeks to assess the effectiveness of upper limb robotic rehabilitation in individuals recovering from subacute strokes, in comparison to conventional treatments. Specifically, it aims to determine whether this robotic therapy can lead to improvements in (a) cognitive deficits, (b) somatosensory impairment, and (c) how these sensory and cognitive deficits influence the process of motor recovery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
126

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Nov 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 31, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

November 13, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1.5 years

First QC Date

October 23, 2023

Last Update Submit

October 10, 2024

Conditions

Keywords

roboticscognitionrehabilitationupper extremitysensorimotor

Outcome Measures

Primary Outcomes (1)

  • Changes in Montreal Cognitive Assessment

    It is a validated test of cognitive impairment. It ranges from 0 (indicating worse cognitive function) to 30 (best cognitive function).

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention

Secondary Outcomes (17)

  • Changes in Montreal Cognitive Assessment

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • Changes in Symbol Digit Modalities Test

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • Changes in Tower of London

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • Changes in Rey-Osterrieth Complex Figure test

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • Changes in Visual search test

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • +12 more secondary outcomes

Other Outcomes (9)

  • Changes in robotic score duration

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • Changes in robotic score speed

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • Changes in robotic score length

    Baseline, up to 7 days after the enrollment; up to 3 days after the intervention; 6 months after the end of the intervention

  • +6 more other outcomes

Study Arms (2)

Robotic Rehabilitation

EXPERIMENTAL
Other: Robotic Rehabilitation of the upper limb

Conventional treatment

ACTIVE COMPARATOR
Other: Conventional Rehabilitation of the upper limb

Interventions

Upper limb rehabilitation using a set of 4 devices. A set of motor/cognitive exercises will be selected to train also attention, memory, executive function, speed of processing, and visuospatial abilities.The following devices will be used: (a) a robotic device that allows passive, active, and active-assistive planar movements of the shoulder and elbow joints (Motore, Humanware); (b) a robotic device that allows passive, active, and active-assistive finger flexion and extension movements (Amadeo, Tyromotion); (c) a sensor-based system that allows unsupported 3-dimensional movements of shoulder, elbow, and wrist joint, both unimanual and bimanual (Pablo, Tyromotion); and (d) a robotic system that allows 3-dimensional, unimanual and bimanual, movements of the shoulder joint, with arm weight support (Diego, Tyromotion). The rehabilitation treatment will be performed daily for 45 minutes, 5 days/week, for a total of 30 sessions.

Robotic Rehabilitation

Upper limb rehabilitation using conventional techniques, focused on upper limb reprogramming sensorimotor function, hypertonus, inhibition and functional improvement. The rehabilitation treatment will be performed daily for 45 minutes, 5 days/week, for a total of 30 sessions.

Conventional treatment

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a single event, verified by MRI or CT;
  • age between 18 and 85 years;
  • time since stroke within six months;
  • a demographically adjusted total score of the Montreal Cognitive Assessment (MoCA) between 15.5 and 22.23

You may not qualify if:

  • behavioural and cognitive disorders and/or reduced compliance that would interfere with active therapy;
  • fixed contraction deformity in the affected limb that would interfere with active therapy (ankylosis, Modified Ashworth Scale = 4);
  • severe deficits in visual acuity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

IRCCS Fondazione Don Carlo Gnocchi

Florence, 50143, Italy

RECRUITING

IRCCS Centro Neurolesi Bonino Pulejo

Messina, 98123, Italy

RECRUITING

Fondazione Don Carlo Gnocchi - Centro Santa Maria della Provvidenza

Roma, 00166, Italy

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Marco Germanotta, PhD

    IRCCS Fondazione Don Carlo Gnocchi

    STUDY DIRECTOR

Central Study Contacts

Marco Germanotta, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2023

First Posted

October 31, 2023

Study Start

November 13, 2023

Primary Completion

May 1, 2025

Study Completion

January 1, 2026

Last Updated

October 15, 2024

Record last verified: 2024-10

Locations